Imunon, Inc. financial data

Symbol
IMNN on Nasdaq
Location
Lawrenceville, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 136% % -39%
Debt-to-equity 200% % 156%
Return On Equity -501% % -118%
Return On Assets -167% % -29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,070,354 shares -79%
Common Stock, Shares, Outstanding 2,896,273 shares -80%
Entity Public Float $10,800,000 USD -9.2%
Common Stock, Value, Issued $28,963 USD -80%
Weighted Average Number of Shares Outstanding, Basic 2,943,655 shares 128%
Weighted Average Number of Shares Outstanding, Diluted 2,943,655 shares 128%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $7,523,993 USD -42%
General and Administrative Expense $7,011,180 USD -12%
Operating Income (Loss) $14,535,173 USD 31%
Nonoperating Income (Expense) $46,704 USD -60%
Net Income (Loss) Attributable to Parent $14,329,403 USD 26%
Earnings Per Share, Basic 6 USD/shares 69%
Earnings Per Share, Diluted 6 USD/shares 69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,250,929 USD -49%
Cash, Cash Equivalents, and Short-term Investments $5,300,000 USD -49%
Assets, Current $7,257,685 USD -42%
Property, Plant and Equipment, Net $601,425 USD 6.7%
Operating Lease, Right-of-Use Asset $1,078,623 USD -13%
Other Assets, Noncurrent $1,128,623 USD -13%
Assets $8,987,733 USD -38%
Employee-related Liabilities, Current $1,687,690 USD 16%
Accrued Liabilities, Current $2,676,951 USD 4%
Liabilities, Current $4,197,912 USD -23%
Operating Lease, Liability, Noncurrent $708,097 USD -6.6%
Liabilities $4,906,009 USD -21%
Accumulated Other Comprehensive Income (Loss), Net of Tax $133,101 USD 7.4%
Retained Earnings (Accumulated Deficit) $417,075,222 USD -3.6%
Stockholders' Equity Attributable to Parent $4,081,724 USD -50%
Liabilities and Equity $8,987,733 USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,847,051 USD 52%
Net Cash Provided by (Used in) Financing Activities $105,692 USD
Net Cash Provided by (Used in) Investing Activities $259,652 USD -111%
Common Stock, Shares Authorized 350,000,000 shares 211%
Common Stock, Shares, Issued 2,896,275 shares -80%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,001,011 USD 14%
Deferred Tax Assets, Valuation Allowance $74,634,333 USD 2.3%
Deferred Tax Assets, Gross $74,634,333 USD 0.51%
Operating Lease, Liability $1,102,232 USD -13%
Depreciation $66,681 USD -5.1%
Payments to Acquire Property, Plant, and Equipment $259,652 USD 2109%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $15,745,753 USD 13%
Lessee, Operating Lease, Liability, to be Paid $1,256,999 USD -14%
Property, Plant and Equipment, Gross $1,737,567 USD -39%
Operating Lease, Liability, Current $394,135 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Two $498,086 USD 37%
Lessee, Operating Lease, Liability, to be Paid, Year One $488,821 USD -10%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) $1,280,385 USD -18%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $154,767 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three $370,235 USD 2%
Deferred Tax Assets, Operating Loss Carryforwards $66,141,490 USD -1.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100,000 shares 0%
Unrecognized Tax Benefits $0 USD
Operating Lease, Payments $662,332 USD 3.4%
Additional Paid in Capital $421,213,171 USD 2.5%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%